Skip to main content
OpenTrials

Clinical trial condition

Metastatic Urothelial Carcinoma

Explore clinical trials studying Metastatic Urothelial Carcinoma. Study availability and eligibility vary by location and protocol.

53 public trials 18 recruiting studies
Refine in advanced search Browse all conditions

Metastatic Urothelial Carcinoma trial results

Active, Not Recruiting

Trying to Find the Correct Length of Treatment With Immune Checkpoint Therapy

NCT04637594

Conditions
Carcinoma, Carcinoma, Transitional Cell, Locally Advanced Bladder Urothelial Carcinoma, +12 more
Locations
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
View all 377 locations
View Trial Details
Active, Not Recruiting

A Study of Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Plus Enfortumab Vedotin (EV) With and Without Pembrolizumab in Advanced Urothelial Carcinoma (MK-3475-04C/KEYMAKER-U04)

NCT06483334

Conditions
Carcinoma, Carcinoma, Transitional Cell, Locally Advanced Urothelial Carcinoma, +5 more
Locations
  • University of California San Francisco HDFCCC ( Site 4044) San Francisco, California, United States
  • University of Chicago Medical Center ( Site 4037) Chicago, Illinois, United States
  • Indiana University Melvin and Bren Simon Cancer Center ( Site 4011) Indianapolis, Indiana, United States
  • Dana-Farber Cancer Institute ( Site 4047) Boston, Massachusetts, United States
View all 25 locations
View Trial Details
Active, Not Recruiting

Safety and Preliminary Anti-Tumor Activity of TYRA-300 in Advanced Urothelial Carcinoma and Other Solid Tumors With FGFR3 Gene Alterations

NCT05544552

Conditions
Advanced Solid Tumor, Advanced Urothelial Carcinoma, Bladder Cancer, +31 more
Locations
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • UMass Memorial Medical Center Worchester, Massachusetts, United States
  • Memorial Sloan Kettering Cancer Center (MSKCC) New York, United States
  • Duke Cancer Institute (DCI) - Duke Cancer Center Durham, North Carolina, United States
View all 19 locations
View Trial Details
Active, Not Recruiting

A Study to Compare the Results of FGFR Testing by Either ctDNA Blood Testing or Standard Tumor Tissue Testing

NCT06129084

Conditions
Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +14 more
Locations
  • Arthur J.E Child Comprehensive Cancer Centre Calgary, Alberta, Canada
  • Cross Cancer Institute Edmonton, Alberta, Canada
  • BC Cancer Agency Vancouver, British Columbia, Canada
  • London Health Sciences Centre London, Ontario, Canada
View Trial Details

Related conditions